NCT02892305Active, not recruiting
Hepatic Resection for Metastatic Pancreatic Cancer
Source: ClinicalTrials.gov · Last updated 27 Aug 2026
Brief summary (registry, in English)
The purpose of this study is to demonstrate the feasibility of an aggressive multimodal approach among patients with stage IV pancreatic cancer (PAC) with isolated, low-volume hepatic metastasis (LVHM). We will evaluate and describe the surgical and overall outcomes of an initial cohort of subjects who undergo pancreatectomy and hepatic resection/ablation for PAC with LVHM. The end of study results will be reviewed by the Hepatiobiliary Multidisciplinary Conference (HDMC) and Surgery Audit Committee (SAC) to determine the appropriateness of adding this treatment arm for patients with oligometastatic metastatic pancreatic cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 18 (actual)
- First submitted
- 29 Aug 2016
- Start date
- 18 May 2018
- Primary completion date
- 17 May 2023
- Lead sponsor
- Duke University
- Diseases
- Pancreatic cancer
- NCT number
- NCT02892305
What you commit to
- Study type: Observational
- Participants enrolled: 18
- From 18 May 2018 to the primary completion date, 17 May 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subject is not a suitable candidate for surgical intervention
Other
- The Hepatobiliary Multidisciplinary Committee (HDMC) disapproves of this intervention.
- Insurance will not cover the procedure or subject not willing to pay out of pocket.
- Pregnant women
- Non-English speaking Subjects
Who the study is looking for
- Subject must be at least 18 years of age and at least the minimum Age of Majority according to applicable State or Country Law
- Subject is a surgical candidate, (i.e., is able to undergo general anesthesia and surgical resection for diagnosis of cancer)
- The Hepatobiliary Multidisciplinary Committee (HDMC) must approved of this intervention.
- Insurance pre-authorization must be received unless the subject decides to pay out of pocket..
- Subject has been informed of the study procedures and the treatment and has signed an informed consent form
- less than or equal to 3 liver lesions
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Duke University Health System Coordinator of this site? Confirm its status | Durham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.